231 related articles for article (PubMed ID: 33140095)
1. PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.
Yi K; Zhan Q; Wang Q; Tan Y; Fang C; Wang Y; Zhou J; Yang C; Li Y; Kang C
Neuro Oncol; 2021 Mar; 23(3):387-399. PubMed ID: 33140095
[TBL] [Abstract][Full Text] [Related]
2. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.
Yi K; Cui X; Liu X; Wang Y; Zhao J; Yang S; Xu C; Yang E; Xiao M; Hong B; Fang C; Kang C; Tan Y; Wang Q
Front Immunol; 2021; 12():802795. PubMed ID: 35069587
[TBL] [Abstract][Full Text] [Related]
3. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
Zhan Q; Yi K; Cui X; Li X; Yang S; Wang Q; Fang C; Tan Y; Li L; Xu C; Yuan X; Kang C
Neuro Oncol; 2022 Nov; 24(11):1871-1883. PubMed ID: 35312010
[TBL] [Abstract][Full Text] [Related]
4. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
[No Abstract] [Full Text] [Related]
5. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
[TBL] [Abstract][Full Text] [Related]
6. Polymerase I and transcript release factor acts as an essential modulator of glioblastoma chemoresistance.
Wang X; Liu T; Bai Y; Liao H; Qiu S; Chang Z; Liu Y; Yan X; Guo H
PLoS One; 2014; 9(4):e93439. PubMed ID: 24747515
[TBL] [Abstract][Full Text] [Related]
7. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.
Mishra S; Charan M; Shukla RK; Agarwal P; Misri S; Verma AK; Ahirwar DK; Siddiqui J; Kaul K; Sahu N; Vyas K; Garg AA; Khan A; Miles WO; Song JW; Bhutani N; Ganju RK
J Exp Clin Cancer Res; 2022 Feb; 41(1):54. PubMed ID: 35135586
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide has anti-tumor effects through the phosphorylation of cPLA
Tsuji S; Ohno Y; Nakamura S; Yamada T; Noda Y; Saio M; Iwama T; Shimazawa M; Hara H
Brain Res; 2019 Nov; 1723():146396. PubMed ID: 31442413
[TBL] [Abstract][Full Text] [Related]
9. Polymerase I and transcript release factor transgenic mice show impaired function of hematopoietic stem cells.
Bai L; Lyu Y; Shi G; Li K; Huang Y; Ma Y; Cong YS; Zhang L; Qin C
Aging (Albany NY); 2020 Oct; 12(20):20152-20162. PubMed ID: 33087586
[TBL] [Abstract][Full Text] [Related]
10. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
Front Immunol; 2020; 11():1281. PubMed ID: 32765489
[No Abstract] [Full Text] [Related]
11. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
12. IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells.
Salani B; Passalacqua M; Maffioli S; Briatore L; Hamoudane M; Contini P; Cordera R; Maggi D
PLoS One; 2010 Nov; 5(11):e14157. PubMed ID: 21152401
[TBL] [Abstract][Full Text] [Related]
13. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
15. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
16. PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9.
Aung CS; Hill MM; Bastiani M; Parton RG; Parat MO
Eur J Cell Biol; 2011; 90(2-3):136-42. PubMed ID: 20732728
[TBL] [Abstract][Full Text] [Related]
17. PTRF suppresses the progression of colorectal cancers.
Wang F; Zheng Y; Orange M; Yang C; Yang B; Liu J; Tan T; Ma X; Chen T; Yin X; Tang X; Zhu H
Oncotarget; 2017 Jul; 8(30):48650-48659. PubMed ID: 27203393
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of polymerase-1 and transcript release factor (PTRF/ Cavin-1) in health and disease.
Low JY; Nicholson HD
Cell Tissue Res; 2014 Sep; 357(3):505-13. PubMed ID: 25107607
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
[TBL] [Abstract][Full Text] [Related]
20. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
